Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Korean surgeons operate on 99-year-old with torn aorta despite 30% survival odds

4+ hour, 50+ min ago   (356+ words) A 99-year-old man in Seoul has survived emergency heart surgery that his doctors thought he had little better than a one-in-three chance of surviving, after they concluded the alternative would kill him within a week. Lee Seung-man, a retired primary…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Why do some rheumatic diseases resist treatment? Mathematical model offers clues

2+ week, 1+ day ago   (311+ words) Korean researchers have developed a mathematical model that may explain why patients with the same rheumatic disease respond differently to the same treatment. Soon Chun Hyang University Hospital Bucheon said Tuesday that a research team led by Professors Jung Sung-soo,…...

KBR
koreabiomed.com > news > articleView.html

Kolon TissueGene’s knee osteoarthritis therapy misses both endpoints in US phase 3 trial

1+ mon, 2+ week ago   (379+ words) Kolon TissueGene's experimental knee osteoarthritis therapy TG-C failed to beat a placebo on either of its two main measures in the first of two pivotal U.S. trials, the company said on Monday. In the trial, called TGC-15302, patients given a single…...

KBR
koreabiomed.com > news > articleView.html

Vivozon's oral non-opioid pain candidate shows encouraging efficacy trend in phase 2

2+ mon, 2+ day ago   (373+ words) Vivozon Pharmaceutical said Monday that its affiliate Vivozon's oral non-opioid analgesic candidate, VVZ-2471, showed an encouraging efficacy trend, particularly in the high-dose group, in a phase 2 trial. VVZ-2471 is an oral non-opioid analgesic candidate discovered using the company's multi-target drug…...

KBR
koreabiomed.com > news > articleViewAmp.html

Rinvoq reimbursement expansion gives ankylosing spondylitis patients earlier access to oral therapy

2+ mon, 1+ week ago   (844+ words) The expanded reimbursement of Rinvoq in ankylosing spondylitis has opened a new treatment path for patients who fail conventional oral therapies, allowing them to move directly to an advanced oral option without first undergoing biologic treatment. AbbVie Korea held a…...

KBR
koreabiomed.com > news > articleView.html

SK chemicals launches coin-sized Trast pain relief patch

3+ mon, 3+ week ago   (187+ words) SK chemicals has launched a coin-sized version of its Trast pain relief patch line. The company said Thursday that it released Trast Coin Plaster, a small topical patch for localized pain areas. Trast Coin Plaster is an over-the-counter medication containing…...

KBR
koreabiomed.com > news > articleViewAmp.html

You experience intense, persistent pain, but all tests show nothing. Why?

4+ mon, 2+ week ago   (274+ words) Sometimes, people experience intense, tingling pain in their hands or fingers -- severe enough to wake them at night -- yet scans such as MRI show no clear abnormality. In these cases, the cause may be neuropathic (nerve) pain. Pain does not…...

KBR
koreabiomed.com > news > articleView.html

Sudden spring workouts raise risk of joint injuries, expert says

5+ mon, 1+ week ago   (487+ words) During springtime outdoor activity, sudden overuse of stiff joints without adequate preparation can lead to injuries throughout the lower limbs, from the hip to the ankle. Korea Biomedical Review spoke with Professor Jeong Sang-jin of the Department of Orthopedic Surgery…...

KBR
koreabiomed.com > news > articleView.html

Hanmi's Naxozole expands label to low back pain following phase 3 results

5+ mon, 2+ week ago   (157+ words) Hanmi Pharmaceutical said Tuesday that its anti-inflammatory painkiller Naxozole (naproxen and esomeprazole) has gained additional approval from the Ministry of Food and Drug Safety to treat low back pain. The company said Naxozole demonstrated pain relief and gastrointestinal safety in…...

KBR
koreabiomed.com > news > articleView.html

The more autologous SVF-derived cells injected, the faster the pain relief: study

7+ mon, 2+ week ago   (254+ words) In autologous adipose-derived stromal vascular fraction (SVF) injection therapy for patients with moderate knee osteoarthritis, a higher number of injected cells was associated with faster pain relief. On Wednesday, Yonsei Sarang Hospital, a joint specialty hospital designated by the Ministry…...